Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.
Cholangiocarcinoma, whether arising from the intrahepatic or extrahepatic biliary system, is a rare but devastating malignancy. Prognosis is poor, with 5-year overall survival <5% including patients undergoing surgery. Resection is the only curative treatment; however, only ∼30% of patients present at a resectable stage, and intrahepatic recurrence is common even after complete resection. This article discusses the current role of transarterial therapies in the treatment of intrahepatic cholangiocarcinoma.
Division of Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Joseph J
JJ
Zechlinski
Division of Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin.
William S
WS
Rilling
chemoembolization; cholangiocarcinoma; outcomes; radioembolization